Breadcrumb Inicio IMPAACT News IMPAACT News News December 2025 Announcements 2025 Year in Review: A Message from Our Network Chairs November 2025 Meetings IMPAACT 2034 Results Presented at 2025 Union World Conference on Lung Health October 2025 Meetings IMPAACT at IAS 2025 and HIV Pediatrics Workshop 2025 Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All2025202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 103 news items. April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV. March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children February 2022 Study Results IMPAACT Shares Study Results in CROI 2022 Oral Presentations February 2022 Study Results IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission February 2022 Study Results IMPAACT Shares Study Results at CROI 2022 Poster Presentations January 2022 Meetings IMPAACT at CROI 2022 November 2021 Announcements IMPAACT Investigator Identifies COVID-19 Omicron Variant November 2021 Announcements IMPAACT Remembers Carol Onyango September 2021 Announcements IMPAACT P1108 Informs WHO TB Management Recommendation Pagination Previous page Prev Página 1 … Página 3 Página 4 Página 5 Página 6 Current page 7 Página 8 Página 9 Página 10 Página 11 Next page Next
April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV.
March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children
February 2022 Study Results IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission
